Consonance Capital Management as of Dec. 31, 2017
Portfolio Holdings for Consonance Capital Management
Consonance Capital Management holds 23 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spectrum Pharmaceuticals | 12.6 | $140M | 7.4M | 18.95 | |
| Corcept Therapeutics Incorporated (CORT) | 9.4 | $104M | 5.8M | 18.06 | |
| Amarin Corporation (AMRN) | 8.9 | $98M | 25M | 4.01 | |
| Gw Pharmaceuticals Plc ads | 8.1 | $89M | 676k | 132.01 | |
| Radius Health | 7.6 | $84M | 2.6M | 31.77 | |
| Retrophin | 6.9 | $77M | 3.6M | 21.07 | |
| MiMedx (MDXG) | 6.8 | $76M | 6.0M | 12.61 | |
| Pacira Pharmaceuticals (PCRX) | 6.6 | $73M | 1.6M | 45.65 | |
| La Jolla Pharmaceuticl Com Par | 6.0 | $67M | 2.1M | 32.18 | |
| Argenx Se (ARGX) | 4.5 | $50M | 784k | 63.14 | |
| Savara (SVRA) | 3.7 | $41M | 2.8M | 14.84 | |
| NuVasive | 3.6 | $40M | 675k | 58.49 | |
| D Stemline Therapeutics | 3.3 | $37M | 2.3M | 15.60 | |
| Urogen Pharma (URGN) | 3.1 | $34M | 917k | 37.21 | |
| Pacific Biosciences of California (PACB) | 1.7 | $19M | 7.1M | 2.64 | |
| Vericel (VCEL) | 1.7 | $18M | 3.4M | 5.45 | |
| Catalyst Pharmaceutical Partners (CPRX) | 1.6 | $18M | 4.5M | 3.91 | |
| Oxford Immunotec Global | 1.4 | $16M | 1.1M | 13.97 | |
| Adma Biologics (ADMA) | 1.0 | $11M | 3.4M | 3.21 | |
| Biosante Pharmaceuticals (ANIP) | 0.8 | $9.2M | 143k | 64.45 | |
| Corindus Vascular Robotics I | 0.6 | $6.0M | 6.0M | 1.01 | |
| Iovance Biotherapeutics (IOVA) | 0.2 | $1.9M | 232k | 8.00 | |
| Seaspine Holdings | 0.0 | $217k | 21k | 10.13 |
